The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
New keys for old locks: carborane-containing drugs as platforms for mechanism-based therapies
Open accessAbstract
Carborane derivatives as a new class of drugs (“new keys”) for important receptors (“old locks”) as targets for efficient therapeutic treatments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design
Meanwell, N. A. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm1013693 · Cited by 2,854
Johnstone, T. C., Suntharalingam, K., & Lippard, S. J. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00597 · Cited by 2,485
Therapeutic peptides: Historical perspectives, current development trends, and future directions
Lau, J. L., & Dunn, M. K. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.06.052 · Cited by 1,879
The P2X7 Receptor in Infection and Inflammation
Di Virgilio, F., Dal Ben, D., Sarti, A. C., Giuliani, A. L., & Falzoni, S. (2017) · Immunity · doi:10.1016/j.immuni.2017.06.020 · Cited by 1,267
Nanodrug Delivery: Is the Enhanced Permeability and Retention Effect Sufficient for Curing Cancer?
Nakamura, Y., Mochida, A., Choyke, P. L., & Kobayashi, H. (2016) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00437 · Cited by 1,101
IDO in the Tumor Microenvironment: Inflammation, Counter-Regulation, and Tolerance
Munn, D. H., & Mellor, A. L. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.01.002 · Cited by 1,041
Wilson and Gisvold's Textbook of Organic Medicinal and Pharmaceutical Chemistry
Beale, J. M., & Block, J. H. (2011) · Andalas University Repository (Andalas University) · Cited by 914
Carbaboranes as Pharmacophores: Properties, Synthesis, and Application Strategies
Scholz, M., & Hey-Hawkins, E. (2011) · Chemical Reviews · doi:10.1021/cr200038x · Cited by 797
Self-citationHasmann, M., & Schemainda, I. (2003) · PubMed · Cited by 617
Boron delivery agents for neutron capture therapy of cancer
Barth, R. F., Mi, P., & Yang, W. (2018) · Cancer Communications · doi:10.1186/s40880-018-0299-7 · Cited by 467
The Practice of Medicinal Chemistry
(2015) · Elsevier eBooks · doi:10.1016/c2012-0-03066-9 · Cited by 383
Challenges and Opportunities for the Application of Boron Clusters in Drug Design
Leśnikowski, Z. J. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01932 · Cited by 348
P2X7 Receptors: Channels, Pores and More
Volonte, C., Apolloni, S., D. Skaper, S., & Burnstock, G. (2012) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152712803581137 · Cited by 254
The Valence Structure of the Boron Hydrides
Eberhardt, W., Crawford, B. L., & Lipscomb, W. N. (1954) · The Journal of Chemical Physics · doi:10.1063/1.1740320 · Cited by 248
Hennequart, M., Pilotte, L., Cane, S., Hoffmann, D., Stroobant, V., Plaen, E. D., & Eynde, B. J. V. D. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-16-0400 · Cited by 171
The First CNS-Active Carborane: A Novel P2X7 Receptor Antagonist with Antidepressant Activity
Wilkinson, S. M., Gunosewoyo, H., Barron, M. L., Boucher, A. A., McDonnell, M., Turner, P., Morrison, D. E., Bennett, M. R., McGregor, I. S., Rendina, L. M., et al. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn500054n · Cited by 147
Wennekes, T., van den Berg, R. J. B. H. N., Donker‐Koopman, W. E., van der Marel, G. A., Strijland, A., Aerts, J. M. F. G., & Overkleeft, H. S. (2007) · The Journal of Organic Chemistry · doi:10.1021/jo061280p · Cited by 135
Expression of glutamate carboxypeptidase II in human brain
Šácha, P., Zámečnı́k, J., Bařinka, C., Hlouchová, K., Vícha, A., Mlčochová, P., Hilgert, I., Eckschlager, T., & Konvalinka, J. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.10.022 · Cited by 131
Hit-to-Lead studies: The discovery of potent adamantane amide P2X7 receptor antagonists
Baxter, A., Bent, J., Bowers, K. C., Braddock, M., Brough, S., Fagura, M., Lawson, M., McInally, T., Mortimore, M., Robertson, M. J., et al. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.08.034 · Cited by 124
Carborane‐Based Carbonic Anhydrase Inhibitors
Brynda, J., Mäder, P., Šícha, V., Fábry, M., Poncová, K., Bakardiev, M., Grüner, B., Cígler, P., & Řezáčová, P. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201307583 · Cited by 103
Şahin, K., Tuzcu, M., Başak, N., Çağlayan, B., Kılıç, Ü., Sahin, F., & Kucuk, O. (2012) · Journal of Oncology · doi:10.1155/2012/461562 · Cited by 96
Couto, M., García, M. F., Alamón, C., Cabrera, M., Cabral, P., Merlino, A., Teixidor, F., Cerecetto, H., & Viñas, C. (2017) · Chemistry - A European Journal · doi:10.1002/chem.201705181 · Cited by 85
Carbonic Anhydrase IX (CAIX) as a Mediator of Hypoxia-Induced Stress Response in Cancer Cells
McDonald, P. C., & Dedhar, S. (2013) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-007-7359-2_13 · Cited by 81
Couto, M., Mastandrea, I., Cabrera, M., Cabral, P., Teixidor, F., Cerecetto, H., & Viñas, C. (2017) · Chemistry - A European Journal · doi:10.1002/chem.201701965 · Cited by 69
Carborane-based design of a potent vitamin D receptor agonist
Otero, R., Seoane, S., Sigüeiro, R., Belorusova, A. Y., Maestro, M. A., Pérez-Fernández, R., Rochel, N., & Mouriño, A. (2015) · Chemical Science · doi:10.1039/c5sc03084f · Cited by 60
ortho-Carbaborane derivatives of indomethacin as cyclooxygenase (COX)-2 selective inhibitors
Scholz, M., Blobaum, A. L., Marnett, L. J., & Hey‐Hawkins, E. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.05.063 · Cited by 55
Self-citationLee, M. W., Sevryugina, Y. V., Khan, A. A., & Ye, S. Q. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300740t · Cited by 53
Buzharevski, A., Paskaš, S., Sárosi, M. B., Laube, M., Lönnecke, P., Neumann, W., Mijatović, S., Maksimović‐Ivanić, D., Pietzsch, J., & Hey‐Hawkins, E. (2019) · ChemMedChem · doi:10.1002/cmdc.201800685 · Cited by 34
Self-citationKöhler, S. C., Vahdati, S., Scholz, M., & Wiese, M. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.01.012 · Cited by 29
Youn, S., Kim, K. I., Ptáček, J., Ok, K., Nováková, Z., Kim, Y., Koo, J., Bařinka, C., & Byun, Y. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.09.062 · Cited by 23
The first indoleamine-2,3-dioxygenase-1 (IDO1) inhibitors containing carborane
Austin, C., Kahlert, J. U., Issa, F., Reed, J. H., Smith, J. R., Ioppolo, J. A., Ong, J. A., Jamie, J. F., Hibbs, D. E., & Rendina, L. M. (2014) · Dalton Transactions · doi:10.1039/c4dt00444b · Cited by 22
Kuhnert, R., Sárosi, M. B., George, S., Lönnecke, P., Hofmann, B., Steinhilber, D., Steinmann, S. M., Schneider‐Stock, R., Murganić, B., Mijatović, S., et al. (2018) · ChemMedChem · doi:10.1002/cmdc.201800651 · Cited by 22
Self-citationCarbORev‐5901: The First Carborane‐Based Inhibitor of the 5‐Lipoxygenase Pathway
Kuhnert, R., Sárosi, M. B., George, S., Lönnecke, P., Hofmann, B., Steinhilber, D., Murganić, B., Mijatović, S., Maksimović‐Ivanić, D., & Hey‐Hawkins, E. (2017) · ChemMedChem · doi:10.1002/cmdc.201700309 · Cited by 19
Self-citationKöhler, S. C., Silbermann, K., & Wiese, M. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.09.010 · Cited by 17
ortho‐Carborane‐Modified N‐Substituted Deoxynojirimycins
Hoogendoorn, S., Mock, E. D., Strijland, A., Donker‐Koopman, W. E., van den Elst, H., van den Berg, R. J. B. H. N., Aerts, J. M. F. G., van der Marel, G. A., & Overkleeft, H. S. (2015) · European Journal of Organic Chemistry · doi:10.1002/ejoc.201500364 · Cited by 11
Huang, P., Lee, M. W., Sadrerafi, K., Heruth, D. P., Zhang, L. Q., Maulik, D., & Ye, S. Q. (2017) · Drug Design Development and Therapy · doi:10.2147/dddt.s125349 · Cited by 11
Diaryl-substituted carboranes as inhibitors of hypoxia inducible factor-1 transcriptional activity
Nakamura, H., Tazaki, L., Kanoh, D., & Sato, S. (2015) · Pure and Applied Chemistry · doi:10.1515/pac-2014-0911 · Cited by 10
Metadata
- Authors
- Stockmann, P., Gozzi, M., Kuhnert, R., Sárosi, M. B., & Hey-Hawkins, E.
- Venue
- Chemical Society Reviews
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2019
- Volume
- 48
- Issue
- 13
- Pages
- 3497-3512
- ISSN
- 0306-0012 (ISSN-L)
- 1460-4744
- OpenAlex
- W2951620617
- Cited by
- 317
- References
- 37
- FWCI
- 6.16
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.